Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events
about
Neurosteroids and GABA(A) Receptor Interactions: A Focus on StressNeurosteroids in the context of stress: implications for depressive disordersAnxiety disorders and GABA neurotransmission: a disturbance of modulationAnesthesia with sevoflurane in neonatal rats: Developmental neuroendocrine abnormalities and alleviating effects of the corticosteroid and Cl(-) importer antagonists.GABAA receptor-acting neurosteroids: a role in the development and regulation of the stress responseEndocrine and neurobehavioral abnormalities induced by propofol administered to neonatal rats.Tolerance to allopregnanolone with focus on the GABA-A receptor.Postnatal serotonin type 2 receptor blockade prevents the emergence of anxiety behavior, dysregulated stress-induced immediate early gene responses, and specific transcriptional changes that arise following early life stress.Effects of an early handling-like procedure and individual housing on anxiety-like behavior in adult C57BL/6J and DBA/2J miceEarly attachment-figure separation and increased risk for later depression: potential mediation by proinflammatory processes.Adrenal steroid hormones and ethanol self-administration in male rhesus macaques.Divergent neuroactive steroid responses to stress and ethanol in rat and mouse strains: relevance for human studies.Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers.Neuroactive steroids and anxiety disorders.Mechanisms of late-onset cognitive decline after early-life stressStress hormone-related psychopathology: pathophysiological and treatment implications.Synthetic neurosteroids on brain protectionOf sound mind and body: depression, disease, and accelerated agingDisadaptive disorders in women: allopregnanolone, a sensitive steroid.Role of progesterone and other neuroactive steroids in anxiety disorders.Dysfunctional astrocytic and synaptic regulation of hypothalamic glutamatergic transmission in a mouse model of early-life adversity: relevance to neurosteroids and programming of the stress response.Programming the brain and behaviour by early-life stress: a focus on neuroactive steroids.Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients.Role of environmental stressors in determining the developmental outcome of neonatal anesthesia.Persistent effects of maternal deprivation on HPA regulation can be reversed by feeding and stroking, but not by dexamethasone.Role of spinal GABAA receptor reduction induced by stress in rat thermal hyperalgesia.High basal serum allopregnanolone levels in overweight girls.
P2860
Q21129366-49E0A63B-9DE5-45DC-94B2-FD5E6B2F7057Q24646222-7E4C25B7-831A-467B-9137-C65497B80E64Q27003916-8BC924D3-729F-4325-BED2-223E3D02B391Q27304384-6C72E8BC-14BC-44F5-BFD9-A4EDF052C5FEQ28241963-ABFE8A45-6E70-4860-8878-2869B73F189FQ30399697-7E3A1BA3-6B7E-4AAF-8419-EB1EFACBDA47Q30471700-67602502-A778-4ACC-9142-2A5C0FF2529AQ30471963-DD826018-7D81-4DD9-9B60-AC249FC340E8Q30475730-EC3AB1BD-9891-4660-BD04-D03B29C229DBQ33767298-8FBB4B82-D83A-401F-9357-02135E69B470Q34053875-EA7A9204-8457-414D-94BB-3F6608DC1167Q34054035-506BE6A5-A5D4-4245-BA66-A2E2AD9F8C2AQ34356272-DBA6C56D-C446-4120-A185-53FB1B531A79Q34687268-4262446F-5A26-4994-95FB-67F8EC8E6907Q35001724-7586FEF1-D74D-48DB-B40C-4BF6273AEF81Q35066496-9DCBB823-010A-4770-A79E-25F3C1769DDAQ35169910-CBBE7E92-995B-457B-9136-081542F6D4CEQ35237227-C314099B-99E5-42AA-891B-7E6FAA0FDB67Q36051183-3943FB68-A4DB-41EC-B0A6-404FB1840FF5Q36106869-A536BFE7-7122-4438-BF4F-B47C42ADCC59Q37381812-1373F454-0363-4647-8C03-94F7CE03877EQ38358214-B038356B-5FAC-4FB9-932D-0934C4E4495DQ43135405-B3C64445-926B-4E6D-AB49-13B150045DD6Q47304376-0B6E2F04-204F-4FA8-A762-0C8D40A89B3EQ48136352-23E367F2-7F33-46F1-96A1-2A4512DAAE15Q48679455-A4F79D24-C619-4F0F-B40F-64CA461D4483Q48681663-82CD4AB9-0054-4F86-A7FA-F0A92BAD7248
P2860
Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neonatal treatment of rats wit ...... s of adverse early life events
@en
Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone
@nl
type
label
Neonatal treatment of rats wit ...... s of adverse early life events
@en
Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone
@nl
prefLabel
Neonatal treatment of rats wit ...... s of adverse early life events
@en
Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone
@nl
P2093
P2860
P356
P1476
Neonatal treatment of rats wit ...... s of adverse early life events
@en
P2093
Almeida OF
Holsboer F
Montkowski A
Patchev VK
Rouskova D
P2860
P304
P356
10.1172/JCI119261
P407
P577
1997-03-01T00:00:00Z